We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coca-Cola
KO
$355B
| $197M | 0.25% |
4,207,074
+226,599
| +6% | +$10.6M |
|
102
Antero Midstream
AM
$10.9B
| $194M | 0.24% |
14,061,306
+6,655,328
| +90% | +$86.9M |
|
|
DCP
103
DELISTED
DCP Midstream, LP
DCP
| $188M | 0.23% |
5,679,044
+826,841
| +17% | +$26.4M |
|
104
Qualcomm
QCOM
$187B
| $184M | 0.23% |
3,221,596
+1,052,071
| +48% | +$56.8M |
|
105
Ulta Beauty
ULTA
$20.8B
| $182M | 0.23% |
522,251
-162,028
| -24% | -$49M |
|
106
Newell Brands
NWL
$2.3B
| $179M | 0.22% |
11,695,108
+1,017,861
| +10% | +$18.7M |
|
|
FDC
107
DELISTED
First Data Corporation
FDC
| $179M | 0.22% |
6,798,567
-8,665,151
| -56% | -$206M |
|
108
AT&T
T
$159B
| $178M | 0.22% |
7,509,372
-38,384
| -0.5% | -$883K |
|
109
Bank of America
BAC
$431B
| $174M | 0.22% |
6,300,608
-447,165
| -7% | -$12.6M |
|
110
ExxonMobil
XOM
$638B
| $173M | 0.22% |
2,142,721
+907,448
| +73% | +$69.2M |
|
111
AstraZeneca
AZN
$263B
| $166M | 0.21% |
2,052,645
+1,201,960
| +141% | +$94.7M |
|
|
HEP
112
DELISTED
Holly Energy Partners, L.P.
HEP
| $165M | 0.2% |
6,104,996
-162,067
| -3% | -$4.71M |
|
113
Ionis Pharmaceuticals
IONS
$8.56B
| $165M | 0.2% |
2,027,449
+7,323
| +0.4% | +$472K |
|
114
Salesforce
CRM
$135B
| $164M | 0.2% |
1,034,588
-74,389
| -7% | -$11.5M |
|
|
AMRN
115
Amarin Corp
AMRN
$291M
| $163M | 0.2% |
392,706
-1,757
| -0.4% | -$634K |
|
116
Amdocs
DOX
$5.44B
| $159M | 0.2% |
2,931,073
-1,008,210
| -26% | -$56.7M |
|
|
APU
117
DELISTED
AmeriGas Partners, L.P.
APU
| $158M | 0.2% |
5,127,675
+208,134
| +4% | +$6.09M |
|
118
NetApp
NTAP
$32.9B
| $158M | 0.2% |
2,273,957
+157,272
| +7% | +$10.2M |
|
119
Suburban Propane Partners
SPH
$1.23B
| $157M | 0.2% |
7,015,333
+1,171,533
| +20% | +$25.9M |
|
|
ENLC
120
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $156M | 0.19% |
12,168,263
+12,134,883
| +36,354% | +$137M |
|
121
Centene
CNC
$33.1B
| $150M | 0.19% |
2,827,505
-1,169
| -0% | -$71K |
|
122
Incyte
INCY
$23.5B
| $149M | 0.19% |
1,737,259
+7,215
| +0.4% | +$587K |
|
123
Align Technology
ALGN
$12.6B
| $148M | 0.18% |
522,069
-7,385
| -1% | -$1.76M |
|
|
SAVE
124
DELISTED
Spirit Airlines, Inc.
SAVE
| $148M | 0.18% |
2,807,700
+440,339
| +19% | +$25.3M |
|
125
Altria Group
MO
$122B
| $146M | 0.18% |
2,544,226
+708,894
| +39% | +$36.2M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.